Global health initiatives and mycetoma management: the unmet promise
Abstract
Global health initiatives have undeniably fuelled substantial progress in combating many neglected tropical diseases (NTDs). These efforts have been largely facilitated by international partnerships, collaborative funding and targeted programmes (frequently involving mass drug administration [MDA]) that have brought visibility and resources to diseases that are targeted for elimination like lymphatic filariasis, trachoma and onchocerciasis, with 49 countries having eliminated at least one NTD. Through programmes aligned with the WHO, governments, non-profit and pharmaceutical companies, millions have benefited from prevention and treatment efforts, underscoring the impact of focused health interventions. However, these success stories reveal critical disparities, for example, diseases and conditions amenable to case management such as lymphoedema and hydrocele from lymphatic filariasis and mycetoma. In this article, we focus on the challenges of mycetoma, a debilitating NTD that remains conspicuously underserved. The case of mycetoma underscores significant gaps in the failed commitments of global health and highlights how these initiatives have often fallen short of the stated goals to address all NTDs comprehensively within the framework of Universal Health Coverage and Sustainable Development. Mycetoma, a complex and chronic infection that primarily affects marginalised populations in arid tropical and subtropical regions, manifests as progressive swelling and deformity,…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.
Read the paper
Related studies
- Challenges and opportunities with drug repurposing: finding strategies to find alternative uses of therapeutics
- Challenges in Chagas Disease Drug Development
- T Cell Specificity: A Great Challenge in Chagas Disease
- Benznidazole treatment leads to DNA damage in Trypanosoma cruzi and the persistence of rare widely dispersed non-replicative amastigotes in mice
- Rapid Molecular Detection of Terbinafine-resistant Dermatophytes
- Identifying novel drugs with new modes of action for neglected tropical fungal skin diseases (fungal skinNTDs) using an Open Source Drug discovery approach
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.